Press release
Biopharmaceutical Contract Manufacturing Market | Competitive Dynamics and Global Outlook 2027
The global biopharmaceutical contract manufacturing market is estimated to be valued at US$ 5,625.0 Mn by the end of 2017 and this is expected to increase to US$ 15,467.8 Mn by the end of 2027, registering a CAGR of 10.6% in terms of value over the forecast period.
View Full Report ToC, Figures and Tables -
https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market
Global Biopharmaceutical Contract Manufacturing Market: Regional Forecast
The global biopharmaceutical contract manufacturing market has been studied across the key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is the largest regional market, estimated to be valued at US$ 5,039.3 Mn by 2027 end, with a CAGR of 9.8%. APEJ is the second largest market for biopharmaceutical contract manufacturing, with a growth rate of 12.2% anticipated during the 10 year forecast period.
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Platform
The report segments the global biopharmaceutical contract manufacturing market on the basis of Platform into Mammalian and Microbial. Mammalian is the largest segment by platform, which is estimated to represent US$ 3,857.2 Mn or 68.6% share of the total market in 2017 and is projected to reach US$ 12,534.5 Mn or 81.0% share by 2027 end, expanding at a CAGR of 12.5% over the forecast period.
Need more Information about R.eport Methodology ?
https://www.futuremarketinsights.com/askus/rep-gb-2982
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Product Type
In terms of product type, the global biopharmaceutical contract manufacturing market is segmented into Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, and Others. Monoclonal Antibodies is the largest segment by product type, with revenues estimated to cross US$ 8,100 Mn by the end of the forecast period and a CAGR of 11.3%.
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Application
The global biopharmaceutical contract manufacturing market is segmented on the basis of application into Clinical and Commercial. The Commercial segment will dominate the global market, with revenues in excess of US$ 12,000 Mn expected to be recorded by the end of 2027 resulting in a CAGR of 11.0%.
Request to view Sample Report -
https://www.futuremarketinsights.com/reports/sample/rep-gb-2982
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Therapeutic Area
On the basis of therapeutic area, the global biopharmaceutical contract manufacturing market is segmented into Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, and Others. Oncology is the largest segment by therapeutic area, expected to be valued at US$ 1,111.1 Mn by the end of 2017. Oncology is also the most lucrative segment. Autoimmune Diseases is the second largest segment by therapeutic area with a market attractiveness index of 1.3.
Global Biopharmaceutical Contract Manufacturing Market: Competitive Landscape
The report features some of the leading companies operating in the global biopharmaceutical contract manufacturing market. Companies profiled include Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim GmbH, Patheon N.V., Rentschler Biotechnologie GmbH, Biomeva GmbH, Probiogen AG, Cytovance Biologics, Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena Plc, Vetter Pharma International GmbH, Sandoz International GmbH, Catalent, Inc., AbbVie Contract Manufacturing (An AbbVie Company), Ajinomoto Althea, Inc.
Biopharmaceutical Contract Manufacturing Market Report is available @ US$ 5000
https://www.futuremarketinsights.com/checkout/2982
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharmaceutical Contract Manufacturing Market | Competitive Dynamics and Global Outlook 2027 here
News-ID: 788463 • Views: …
More Releases from Future Market Insights
Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million …
The global olive stone coffee and beverage roasts market is entering a high-growth decade, fueled by sustainability innovation and evolving specialty coffee culture. Valued at USD 510 million in 2026, the market is projected to reach USD 1,620 million by 2036, expanding at a compelling CAGR of 11.5%.
As consumers increasingly seek beverages that combine sustainability, functionality, and distinctive taste, olive stone-based roasting solutions are transitioning from niche experimentation to structured…
Japan Dried Spent Grain Market to Surpass USD 1.1 Billion by 2036 as Feed Optimi …
Japan's dried spent grain market is entering a decade of steady, value-driven expansion, supported by structured feed demand, brewery byproduct utilization, and rising integration of fiber-rich ingredients into food manufacturing. Industry estimates place the market at USD 784.8 million in 2026, with projections indicating growth to USD 1,109.4 million by 2036, reflecting a CAGR of 3.5%.
Between 2020 and 2026, demand increased from USD 637.5 million to USD 784.8 million, shaped…
USA Food Grade Titanium Dioxide Market to Reach USD 7.3 Million by 2036 Amid Ste …
The demand for food grade titanium dioxide in the USA is valued at USD 4.9 million in 2026 and is projected to reach USD 7.3 million by 2036, expanding at a CAGR of 4.1%. Growth remains moderate yet stable, supported by continued use of titanium dioxide as a whitening and opacifying agent across confectionery coatings, bakery decorations, sauces, dairy analogues, and processed food matrices.
Despite heightened regulatory scrutiny and evolving clean-label…
USA Partially Hydrogenated Oil Market to Reach USD 529.4 Million by 2036 Amid Me …
The demand for partially hydrogenated oil in the USA is projected to rise from USD 309.6 million in 2026 to USD 529.4 million by 2036, expanding at a steady CAGR of 5.5%. While edible applications remain tightly regulated, demand persists across specialty industrial and permitted food-related segments where oxidative stability, viscosity control, and texture performance remain critical.
Despite regulatory constraints on trans fats in conventional food manufacturing, PHOs continue to serve…
More Releases for Biopharma
Biopharma Outsourcing Market to See Massive Growth by 2029 | Keyrus Biopharma, E …
According to HTF Market Intelligence, the Global Biopharma Outsourcing market to witness a CAGR of 10.68% during the forecast period (2023-2029). The Latest Released Biopharma Outsourcing Market Research assesses the future growth potential of the Biopharma Outsourcing market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
Global Biopharma Outsourcing Market 2022 Future Set to Massive Growth | Major Pl …
The "Global Biopharma Outsourcing Market Analysis to 2030" is a particular and top to bottom analysis of the Biopharma Outsourcing industry with an emphasis on the worldwide market trend. The report expects to provide an overview of worldwide Biopharma Outsourcing market detailed market segmentation by service, organization mode, application and geography. The worldwide Biopharma Outsourcing market is predictable to witness high growth during the forecast period. The report gives key…
Biopharma Outsourcing Global Market Outlook - BioPharma Services, Lambda Therape …
The Biopharma Outsourcing Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Biopharma Outsourcing market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of…
Biopharma Outsourcing Market Outlook to 2025: Sartorius, Emcure Pharmaceuticals, …
Biopharma Outsourcing market is also presented to the readers as a holistic snapshot of the competitive landscape within the given forecast period. The report also educates about the market strategies that are being adopted by your competitors and leading organizations. The report also focuses on all the recent industry trends. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where…
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and…
Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 | Key Players : Sartorius, Emcure Pharmaceuticals, BioPharma Services, Baxter Healthcare, Keyrus Biopharma, Quintiles”.
Description:-
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base.
Scope of the Report:
This market encompasses various contract companies that provide clinical trials, drug…
